PVLA: Palvella Therapeutics, Inc. Common Stock Company Profile & Statistics

About

Palvella Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases. Palvella Therapeutics Inc., formerly known as Pieris Pharmaceuticals Inc., is based in WAYNE, Pa.

Info & Links

CEO

Wesley H. Kaupinen

Headquarters

125 Strafford Ave, Suite 360
Wayne, PA 19087, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

103

Employees

Palvella Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

267.98M

Enterprise Value

184.37M

Enterprise Value/EBITDA(ttm)

-13.10

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

5.21

Price to Book(mrq)

1.54

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

Profit Margin(ttm)

-2307.55%

Return on Equity(ttm)

-80.93%

Return on Invested Capital(ttm)

-68.90%

Return on Assets(ttm)

-59.55%

Income Statement

Revenue(ttm)

53.00K

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

53.00K

EBITDA(ttm)³

-14.07M

Net Income Available to Common(ttm)

-17.43M

Diluted EPS(ttm)

-12.10

Share Statistics

Beta (5Y Monthly)

0.68

52-Week Change

S&P 500 52-Week Change

5.43%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

11.02M

Dividend Yield

0.00%

Float⁴

10.50M

% Held by Insiders

6.39%

% Held by Institutions

40.11%

Balance Sheet

Total Cash(mrq)

83.60M

Total Cash Per Share(mrq)

7.59

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

7.33%

Quick Ratio(mrq)

4.82%

Book Value Per Share(mrq)

5.69

Cash Flow

Operating Cash Flow Per Share(ytd)

-4.87

Free Cash Flow(ytd)

-10.84M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

PVLA

Palvella Therapeutics, Inc. Common Stock

Palvella Therapeutics, Inc. Common Stock Profile